The RNA-binding protein KHSRP drives prostate cancer progression through a DUSP6 dependent axis
- 1Department of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730000 China
- 2Gansu Province Clinical Research Center for Urinary System Disease, Lanzhou, Gansu 730030 China
- 3Department of Medicine, Northwest Minzu University, Lanzhou, PR China
Abstract
Background: Prostate cancer (PCa) remains a major clinical challenge, particularly because of its progression to more aggressive disease states, and the molecular mechanisms driving its progression are still incompletely understood. KH-type splicing regulatory protein (KHSRP) is a multifunctional RNA-binding protein involved in post-transcriptional gene regulation, but its role and downstream regulatory mechanisms in PCa remain unclear.
Methods: The clinical relevance of KHSRP in PCa was assessed using public datasets and patient specimens. We assessed the biological functions of KHSRP in vitro and in vivo, identified DUSP6 by integrative RNA-seq and RIP-seq analyses, and further validated the associated signaling and phenotypic changes using Western blotting and functional assays.
Results: KHSRP was significantly upregulated in PCa and was associated with aggressive clinicopathological features and poor prognosis. Functional experiments showed that KHSRP overexpression promoted proliferation, migration, and invasion while suppressing apoptosis in PCa cells, whereas KHSRP knockdown produced the opposite effects. Mechanistically, integrative RNA-seq and RIP-seq analyses identified DUSP6 as a candidate downstream target of KHSRP. Further validation using RNA immunoprecipitation assays and RNA decay assays demonstrated that KHSRP accelerated DUSP6 mRNA decay and repressed DUSP6 expression at the post-transcriptional level. Reduced DUSP6 expression was accompanied by enhanced ERK phosphorylation and coordinated activation of PI3K/AKT/mTOR signaling. Restoration of DUSP6 attenuated the pro-tumorigenic effects of KHSRP and weakened the associated signaling activation. Xenograft assays further confirmed the tumor-promoting role of KHSRP in vivo.
Conclusion: KHSRP drives PCa progression through a DUSP6-dependent signaling axis by repressing DUSP6 at the post-transcriptional level and facilitating coordinated activation of ERK and PI3K/AKT/mTOR signaling. These findings identify a previously unrecognized KHSRP–DUSP6 regulatory axis in PCa and suggest that KHSRP may serve as a potential therapeutic target.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13062-026-00894-1.
Related
- The African swine fever virus I73R protein is a multifunctional Zα domain that mediates both Z-binding-dependent and -independent biological functions through induction of phase separation
- VIRMA-associated SRD5A2 downregulation promotes BPH progression through ERα-CREB5-dependent epithelial plasticity
- Phosphorylation-dependent binding of the Adenomatous Polyposis Coli protein to β-TrCP1 regulates β-catenin destruction
- Dual Carbohydrate Recognition by the Chitinase-like Protein CHI3L1 Through Distinct Glycosaminoglycan and Chitin-Binding Interfaces
- ACTB promotes ESCC progression by regulating the AKT–mTOR signaling pathway through an m6A-dependent mechanism
BibTeX
@article{wang2026rnabinding,
title = {{The RNA-binding protein KHSRP drives prostate cancer progression through a DUSP6 dependent axis}},
author = {Wenyun Wang and Kun Zhao and Yu Zhao and Chengyu You and Yanan Wang and Zhongze Zhou and Qixiang Fang and Xi Xiao and Zhilong Dong},
journal = {Biology Direct},
year = {2026},
month = jul,
doi = {10.1186/s13062-026-00894-1},
url = {https://doi.org/10.1186/s13062-026-00894-1},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - The RNA-binding protein KHSRP drives prostate cancer progression through a DUSP6 dependent axis
AU - Wenyun Wang
AU - Kun Zhao
AU - Yu Zhao
AU - Chengyu You
AU - Yanan Wang
AU - Zhongze Zhou
AU - Qixiang Fang
AU - Xi Xiao
AU - Zhilong Dong
PY - 2026
DA - 2026/07/30
JO - Biology Direct
DO - 10.1186/s13062-026-00894-1
UR - https://doi.org/10.1186/s13062-026-00894-1
AB - Background: Prostate cancer (PCa) remains a major clinical challenge, particularly because of its progression to more aggressive disease states, and the molecular mechanisms driving its progression are still incompletely understood. KH-type splicing regulatory protein (KHSRP) is a multifunctional RNA-binding protein involved in post-transcriptional gene regulation, but its role and downstream regulatory mechanisms in PCa remain unclear. Methods: The clinical relevance of KHSRP in PCa was assessed using public datasets and patient specimens. We assessed the biological functions of KHSRP in vitro and in vivo, identified DUSP6 by integrative RNA-seq and RIP-seq analyses, and further validated the associated signaling and phenotypic changes using Western blotting and functional assays. Results: KHSRP was significantly upregulated in PCa and was associated with aggressive clinicopathological features and poor prognosis. Functional experiments showed that KHSRP overexpression promoted proliferation, migration, and invasion while suppressing apoptosis in PCa cells, whereas KHSRP knockdown produced the opposite effects. Mechanistically, integrative RNA-seq and RIP-seq analyses identified DUSP6 as a candidate downstream target of KHSRP. Further validation using RNA immunoprecipitation assays and RNA decay assays demonstrated that KHSRP accelerated DUSP6 mRNA decay and repressed DUSP6 expression at the post-transcriptional level. Reduced DUSP6 expression was accompanied by enhanced ERK phosphorylation and coordinated activation of PI3K/AKT/mTOR signaling. Restoration of DUSP6 attenuated the pro-tumorigenic effects of KHSRP and weakened the associated signaling activation. Xenograft assays further confirmed the tumor-promoting role of KHSRP in vivo. Conclusion: KHSRP drives PCa progression through a DUSP6-dependent signaling axis by repressing DUSP6 at the post-transcriptional level and facilitating coordinated activation of ERK and PI3K/AKT/mTOR signaling. These findings identify a previously unrecognized KHSRP–DUSP6 regulatory axis in PCa and suggest that KHSRP may serve as a potential therapeutic target. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13062-026-00894-1.
SN - 1745-6150
ER -